Phathom Pharmaceuticals (PHAT)
(Delayed Data from NSDQ)
$16.47 USD
+0.81 (5.17%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $16.45 -0.02 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -1.57 |
EPS Last Quarter | -1.25 |
Last EPS Surprise | -4.17% |
ABR | 1.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.04 |
Next Year | -4.58 |
EPS (TTM) | -4.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 12.54M | 22.59M | 44.03M | 148.57M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 13.42M | 27.82M | 50.48M | 188.40M |
Low Estimate | 11.37M | 16.88M | 38.93M | 121.18M |
Year ago Sales | 0.00M | 0.68M | 0.68M | 44.03M |
Year over Year Growth Est. | NA | 3,222.65% | 6,356.11% | 237.42% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.57 | -1.50 | -6.04 | -4.58 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -1.51 | -1.51 | -5.99 | -4.54 |
High Estimate | -1.51 | -1.48 | -5.99 | -4.54 |
Low Estimate | -1.62 | -1.51 | -6.08 | -4.61 |
Year ago EPS | -0.76 | -0.80 | -2.53 | -6.04 |
Year over Year Growth Est. | -106.58% | -87.50% | -138.74% | 24.17% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.57 | -1.50 | -6.04 | -4.58 |
7 Days Ago | -1.57 | -1.50 | -6.04 | -4.58 |
30 Days Ago | -1.57 | -1.50 | -6.04 | -4.58 |
60 Days Ago | -1.57 | -1.50 | -6.04 | -4.58 |
90 Days Ago | -1.32 | -1.19 | -4.99 | -4.05 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.57 | -1.50 | -6.04 | -4.58 |
Zacks Consensus Estimate | -1.57 | -1.50 | -6.04 | -4.58 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.25 | -1.42 | -0.80 | -0.76 | NA |
Estimate | -1.20 | -1.43 | -0.92 | -0.95 | NA |
Difference | -0.05 | 0.01 | 0.12 | 0.19 | 0.07 |
Surprise | -4.17% | 0.70% | 13.04% | 20.00% | 7.39% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more